Dry eye is a very common condition in many parts of the world. Both ophthalmologists and other healthcare professionals, such as optometrists and general practitioners, are often involved in the care of these patients. The main thrust of dry eye management is over-the-counter tear lubricants. There is a wide range of tear lubricants available today. These lubricants vary in viscosity, duration of action, type of preservatives, osmolarity/osmolality and pH. This article aims to educate healthcare professionals on 1) how to assess and manage patients with mild to moderate dry eyes and 2) how to identify patients who may need a referral to an ophthalmologist. Strategies on the use of available treatments and their limitations, as well as factors that may affect patient compliance will be discussed.
DEWS. The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf2007;5(2):75–92.
2.
TsengSC. Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology1985;92(6):728–33.
3.
CleggJPGuestJFLehmanASmithAF. The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologists. Ophthalmic Epidemiol2006;13(4):263–74.
4.
McCartyCABansalAKLivingstonPMStanislavskyYLTaylorHR. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology1998;105(6):1114–9.
5.
MunozBWestSKRubinGSScheinODQuigleyHABresslerSB. Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study. Arch Ophthalmol2000;118(6):819–25.
6.
SchaumbergDASullivanDABuringJEDanaMR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol2003;136(2):318–26.
7.
FujitaMIgarashiTKuraiTSakaneMYoshinoSTakahashiH. Correlation between dry eye and rheumatoid arthritis activity. Am J Ophthalmol2005;140(5):808–13.
AusayakhunSLouthrenooWAupapongS. Ocular diseases in patients with rheumatic diseases. J Med Assoc Thai2002;85(8):855–62.
10.
BegleyCGCafferyBChalmersRLMitchellGL. Use of the dry eye questionnaire to measure symptoms of ocular irritation in patients with aqueous tear deficient dry eye. Cornea2002;21(7):664–70.
11.
GuptaASadeghiPBAkpekEK. Occult thyroid eye disease in patients presenting with dry eye symptoms. Am J Ophthalmol2009;147(5):919–23.
12.
BegleyCGChalmersRLAbetzLVenkataramanKMertzanisPCafferyBA. The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci2003;44(11):4753–61.
13.
TsubotaKGotoEShimmuraSShimazakiJ. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology1999;106(10):1984–9.
14.
JeonJHShinMSLeeMSJeongSYKangKWKimYI. Acupuncture reduces symptoms of dry eye syndrome: A preliminary observational study. J Altern Complement Med2010;16(12):1291–4.
15.
TomlinsonABronAJKorbDRAmanoSPaughJRPearceEI. The international workshop on meibomian gland dysfunction: Report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci2011;52(4):2006–49.
16.
GeerlingGTauberJBaudouinCGotoEMatsumotoYO'BrienT. The international workshop on meibomian gland dysfunction: Report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci2011;52(4):2050–64.
17.
GolubovicSParunovicA. Cyanoacrylate glue in the treatment of corneal ulcerations. Fortschr Ophthalmol1990;87(4):378–81.
18.
IshiokaMShimmuraSYagiYTsubotaK. Pterygium and dry eye. Ophthalmologica2001;215(3):209–11.
19.
LeeAJLeeJSawSMGazzardGKohDWidjajaD. Prevalence and risk factors associated with dry eye symptoms: A population based study in Indonesia. Br J Ophthalmol2002;86(12):1347–51.
20.
NicholsJJSinnottLT. Tear film, contact lens, and patient-related factors associated with contact lens-related dry eye. Invest Ophthalmol Vis Sci2006;47(4):1319–28.
21.
MathersWDDolneyAMKraemerD. The effect of hormone replacement therapy on the symptoms and physiologic parameters of dry eye. Adv Exp Med Biol2002;506(Pt B):1017–22.
22.
SchaumbergDADanaRBuringJESullivanDA. Prevalence of dry eye disease among US men: Estimates from the Physicians' Health Studies. Arch Ophthalmol2009;127(6):763–8.
23.
OuslerGWWilcoxKAGuptaGAbelsonMB. An evaluation of the ocular drying effects of 2 systemic antihistamines: Loratadine and cetirizine hydrochloride. Ann Allergy Asthma Immunol2004;93(5):460–4.
24.
JabburNSSakataniKO'BrienTP. Survey of complications and recommendations for management in dissatisfied patients seeking a consultation after refractive surgery. J Cataract Refract Surg2004;30(9):1867–74.
25.
ChiaEMMitchellPRochtchinaELeeAJMarounRWangJJ. Prevalence and associations of dry eye syndrome in an older population: The Blue Mountains Eye Study. Clin Experiment Ophthalmol2003;31(3):229–32.
26.
GalorAFeuerWLeeDJFlorezHCarterDPouyehB. Prevalence and Risk Factors of Dry Eye Syndrome in a United States Veterans Affairs Population. Am J Ophthalmol2011;152(3):377–384.e2.
27.
GotoEYagiYMatsumotoYTsubotaK. Impaired functional visual acuity of dry eye patients. Am J Ophthalmol2002;133(2):181–6.
28.
LanWTongL. Comments: Acupuncture for treating dry eye: A randomized placebo-controlled trial. Acta Ophthalmol2011;89(4):e371–2; author reply e372.
29.
ReijulaKSundman-DigertC. Assessment of indoor air problems at work with a questionnaire. Occup Environ Med2004;61(1):33–8.
30.
TsubotaKNakamoriK. Dry eyes and video display terminals. N Engl J Med1993;328(8):584.
31.
RashidSJinYEcoiffierTBarabinoSSchaumbergDADanaMR. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol2008;126(2):219–25.
AsbellPA. Increasing importance of dry eye syndrome and the ideal artificial tear: Consensus views from a roundtable discussion. Curr Med Res Opin2006;22(11):2149–57.
34.
PflugfelderSC. Antiinflammatory therapy for dry eye. Am J Ophthalmol2004;137(2):337–42.
35.
CovellLL. Glaucoma induced by systemic steroid therapy. Am J Ophthalmol1958;45(1):108–9.
36.
MurubeJMurubeAZhuoC. Classification of artificial tears. II: Additives and commercial formulas. Adv Exp Med Biol1998;438:705–15.
37.
DoughtyMJGlavinS. Efficacy of different dry eye treatments with artificial tears or ocular lubricants: A systematic review. Ophthalmic Physiol Opt2009;29(6):573–83.
38.
LiuLTiffanyJDangZDartJKWatsonSLDanielsJT. Nourish and nurture: Development of a nutrient ocular lubricant. Invest Ophthalmol Vis Sci2009;50(6):2932–9.
BergerJSHeadKRSalmonTO. Comparison of two artificial tear formulations using aberrometry. Clin Exp Optom2009;92(3):206–11.
41.
RidderWH3rdLamotteJONgoLFerminJ. Short-term effects of artificial tears on visual performance in normal subjects. Optom Vis Sci2005;82(5):370–7.
42.
GobbelsMSpitznasM. Influence of artificial tears on corneal epithelium in dry-eye syndrome. Graefes Arch Clin Exp Ophthalmol1989;227(2):139–41.
43.
NoeckerRJHerrygersLAAnwaruddinR. Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea. 2004; 23(5): 490–6.
44.
PisellaPJPouliquenPBaudouinC. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol2002;86(4):418–23.
BernalD LopezUbelsJL. Quantitative evaluation of the corneal epithelial barrier: Effect of artificial tears and preservatives. Curr Eye Res1991;10(7):645–56.
47.
SuzukiMMassingaleMLYeFGodboldJElfassyTVallabhajosyulaM. Tear osmolarity as a biomarker for dry eye disease severity. Invest Ophthalmol Vis Sci2010;51(9):4557–61.
48.
LempMABronAJBaudouinCDel CastilloJM BenitezGeffenDTauberJ. Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol2011;151(5):792–798 e1.
49.
GilbardJPRossiSR. An electrolyte-based solution that increases corneal glycogen and conjunctival goblet-cell density in a rabbit model for keratoconjunctivitis sicca. Ophthalmology1992;99(4):600–4.
50.
LentonLMAlbietzJM. Effect of carmellose-based artificial tears on the ocular surface in eyes after laser in situ keratomileusis. J Refract Surg1999;15(2 Suppl):S227–31.
51.
TroianoPMonacoG. Effect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: A cross-over study. Cornea2008;27(10):1126–30.
52.
StahlUWillcoxMStapletonF. Role of hypo-osmotic saline drops in ocular comfort during contact lens wear. Cont Lens Anterior Eye2010;33(2):68–75.
53.
WrightPCooperMGilvarryAM. Effect of osmolarity of artificial tear drops on relief of dry eye symptoms: BJ6 and beyond. Br J Ophthalmol1987;71(2):161–4.
54.
Lopez-AlemanyAMontes-MicoRGarcia-ValldecabresM. Ocular physiology and artificial tears. J Am Optom Assoc1999;70(7):455–60.
55.
Lopez-AlemanyAMontes-MicoRGarcia-ValldecabresM. Do artificial tears have an adequate pH?Contactologia1999;21:51–5.
56.
NornMS. Tear fluid pH in normals, contact lens wearers, and pathological cases. Acta Ophthalmol (Copenh)1988;66(5):485–9.
57.
YamadaMMochizukiHKawaiMYoshinoMMashimaY. Fluorophotometric measurement of pH of human tears in vivo. Curr Eye Res1997;16(5):482–6.
58.
KhuranaAKChaudharyRAhluwaliaBKGuptaS. Tear film profile in dry eye. Acta Ophthalmol (Copenh)1991;69(1):79–86.
59.
CarneyLGHillRM. Human tear pH. Diurnal variations. Arch Ophthalmol1976;94(5):821–4.
60.
LaibovitzRASolchSAndrianoKO'ConnellMSilvermanMH. Pilot trial of cyclosporine 1% ophthalmic ointment in the treatment of keratoconjunctivitis sicca. Cornea1993;12(4):315–23.
61.
MaissaCGuillonMSimmonsPVehigeJ. Effect of castor oil emulsion eyedrops on tear film composition and stability. Cont Lens Anterior Eye2010;33(2):76–82.
62.
YuJAscheCVFairchildCJ. The economic burden of dry eye disease in the United States: A decision tree analysis. Cornea2011;30(4):379–87.
63.
Wan-YuZYue-HongL. A survey on treatment of dry eye by traditional chinese medicine and integrative Chinese and Western medicine. Chinese Journal of Integrative Medicine2006;12(2):154–9.
64.
SwansonM. Compliance with and typical usage of artificial tears in dry eye conditions. J Am Optom Assoc1998;69(10):649–55.
65.
TaylorSAGalbraithSMMillsRP. Causes of non-compliance with drug regimens in glaucoma patients: A qualitative study. J Ocul Pharmacol Ther2002;18(5):401–9.
